Online methods videos go mainstream

Scientific and medical publisher Wiley-Blackwell announced this week (February 20) that they will work with the linkurl:Journal of Visualized Experiments;http://www.the-scientist.com/blog/display/37167/ (JoVE), the first online video methods journal, to add methods videos to the journal linkurl:Current Protocols.;http://www.currentprotocols.com/WileyCDA/ Rumors of JoVE's deal with Wiley-Blackwell and other mainstream science publishers have been circulating in the blogosphere since late January

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Scientific and medical publisher Wiley-Blackwell announced this week (February 20) that they will work with the linkurl:Journal of Visualized Experiments;http://www.the-scientist.com/blog/display/37167/ (JoVE), the first online video methods journal, to add methods videos to the journal linkurl:Current Protocols.;http://www.currentprotocols.com/WileyCDA/ Rumors of JoVE's deal with Wiley-Blackwell and other mainstream science publishers have been circulating in the blogosphere since late January. Moshe Pritsker, CEO of JoVE, told The Scientist this week that he had also signed similar deals with Annual Reviews and linkurl:Springer Protocols.;http://springerprotocols.com/cdp/access/showVideos JoVE has about 200 methods videos on its Web site; the Wiley-Blackwell deal plans for another 200 in the coming year. According to Pritsker, the company has a network of video teams on the ready in cities in the US, Canada and Japan who can film and edit the video. Because the videos require intensive editing (10 or 15 minutes of video from, say, a three to four hour experiment) and technical expertise, they're expensive to produce, he said, though he refused to give an estimate of the cost. (Last summer, for a linkurl:news story;http://www.the-scientist.com/news/display/53500/ in The Scientist on video imaging, Pritsker estimated the cost of making a video at a few hundred dollars, but that's no longer the case: "As the professional level of our videos increased, our production expenses increased too," he wrote in an Email to me yesterday.) "Our idea is to become the video platform of the biological sciences," Pritsker said.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies